Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)
Cancer Chemotherapy and Pharmacology1992Vol. 31(S1), pp. S1–S6
Citations Over Time
Saburo Kawai, Jun Okamura, Makoto Ogawa, Yasuo Ohashi, Masayoshi Tani, J. Inoue, Yoshifumi Kawarada, Mitsuo Kusano, Yasuhiko Kubo, C Kuroda, Yu Sakata, Y Shimamura, Kenji Jinno, Akira Takahashi, Kenichi Takayasu, Kazuo Tamura, Naofumi Nagasue, Yoshimi Nakanishi, M Makino, Manabu Masuzawa, S Mikuriya, Morito Monden, Yasuhiro Yumoto, Takesada Mori, Toshitsugu Oda, The Cooperative Study Group for Liver Cancer Treatment of Japan
Related Papers
- → Prognostic Factors in Patients with Hepatocellular Carcinoma Treated by Transcatheter Arterial Embolization(2002)29 cited
- [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US].(1998)
- Therapeutic Effect of Transcatheter Arterial Chemoembolization in Young Patients with Unresectable Hepatocellular Carcinoma(2001)
- Clinical Curative Effect of High-dose Thermo-lipiodol Embolization in Treatment of Huge Hepatocellular Carcinoma(2011)
- → Lipiodol-induced Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(2022)